No Data
No Data
There's No Escaping Xilinmen Furniture Co.,Ltd's (SHSE:603008) Muted Earnings
Dizhe Pharmaceutical "Xilinmen Furniture": Innovative products successfully enter medical insurance and Refinancing has been approved.
Shanghai, December 11, 2024 /PR Newswire/ -- On December 11, 2024, Di Zhe Pharmaceutical announced that its Private Placement plan on the Star has been approved by the Shanghai Stock Exchange. This marks the first approval for refinancing for an unprofitable company since the release of the China Securities Regulatory Commission's "Eight Measures to Deepen the Reform of the Star, Serving Technological Innovation and the Development of New Productive Forces." On November 28, the National Healthcare Security Administration held a press conference to introduce the results of the 2024 adjustments to the national basic Medical, work-related injury insurance, maternity insurance Pharmaceutical catalog for two innovative source products under Di Zhe Pharmaceutical.
Xilinmen Furniture Co.,Ltd's (SHSE:603008) Largest Shareholders Are Retail Investors Who Were Rewarded as Market Cap Surged CN¥803m Last Week
xilinmen furniture (603008.SH) has repurchased a total of 4.472 million shares, at a cost of 79.9814 million yuan.
xilinmen furniture (603008.SH) announced that as of November 30, 2024, the company has completed the centralized bidding...
Should You Investigate Xilinmen Furniture Co.,Ltd (SHSE:603008) At CN¥18.58?
Xilinmen furniture (603008.SH): has repurchased 1.18% of the shares.
On November 12, xilinmen furniture (603008.SH) announced that as of November 12, 2024, the company has repurchased a total of 4,472,000 shares through centralized auction trading, accounting for 1.18% of the total share capital of the company, an increase of 0.39% compared to the last disclosed number. The highest fill price was 20.60 yuan/share, the lowest fill price was 14.83 yuan/share, and the total funds paid were RMB 79.9814 million (excluding transaction fees).